Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    Saw Palmetto | NCCAM
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Complementary and Alternative Medicine for Urological Symptoms(CAMUS)
Condition: Urological
Interventions: Drug: Saw Palmetto - first 24 weeks;   Drug: Placebo - first 24 weeks;   Drug: Saw Palmetto - weeks 24 - 48;   Drug: Placebo - weeks 24 - 48;   Drug: Saw Palmetto - weeks 48 - 72;   Drug: Placebo - weeks 48 - 72
2 Completed Saw Palmetto Extract in Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Saw Palmetto

Indicates status has not been verified in more than two years